The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials

Kim J.H.Diaz-Decaro J.Jiang N.Hwang S.-J.Choo E.J.Co M.Hastie A.Hui D.S.C.Irimajiri J.Lee J.Leung E.M.-F.Tang H.Tsuru T.Watson P.Wu Z.CHONG-JEN YUYuan Y.Zahaf T.Cunningham A.L.Schuind A.on behalf of the ZOE-50/70 Asian study group2022-06-272022-06-2720212164-5515https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101244231&doi=10.1080%2f21645515.2020.1859321&partnerID=40&md5=5ce36e36b82fdcbe1fb8f0fa2e3217a4https://scholars.lib.ntu.edu.tw/handle/123456789/614002[SDGs]SDG3The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trialsjournal article10.1080/21645515.2020.1859321336065772-s2.0-85101244231